Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach
This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science]
Κύριοι συγγραφείς: | , , , |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
© 2011 Journal of Applied Pharmaceutical Science
2016
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/7113 |
id |
10361-7113 |
---|---|
record_format |
dspace |
spelling |
10361-71132016-12-04T10:11:50Z Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach Asaduzzaman, Md. Rahman, Md. Rezowanur Rahman Khan, Md. Saifur Islam, S.M. Ashraful Department of Mathematics and Natural Sciences, BRAC University Kinetic approach Methocel K4M CR Ranolazine Sustained release This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science] In this study an attempt was made to design and evaluate oral sustained release matrix tablets of ranolazine using Methocel K4M CR as the retardant polymer. Tablets were prepared by conventional wet granulation technique. Tablets were evaluated for parameters such as weight variation, hardness, friability and drug content. All the formulations showed compliance with pharmacopieal standards. In vitro release studies were performed using USP type II apparatus (paddle method) in 900 mL of 0.1N HCl at 50 rpm for 8 hours. The release kinetics was analyzed using the zero-order, first order, Higuchi, Hixson-Crowell and Korsmeyer-Peppas equations to explore and explain the mechanism of drug release from the matrix tablets. In vitro release studies revealed that percent drug release decreased with increase of polymer loading. Based on the dissolution data comparison with innovator brand F-5 formulation (16% Methocel K4M CR w/w of drug) was elected as the best formulation. The drug release profile of the best formulation was well controlled and uniform throughout the dissolution studies. The drug release of optimized formulation follows the Higuchi kinetic model (R2 = 0.99) and the mechanism is found to be non-Fickian/anomalous according to Korsmeyer-Peppas equation. All the formulations were checked for stability as per ICH guidelines and formulations were found stable during the study. Published 2016-12-04T10:10:18Z 2016-12-04T10:10:18Z 2011-10 Article Asaduzzaman, M., Rahman, M. R., Rahman Khan, M. S., & Ashraful Islam, S. M. (2011). Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach. Journal of Applied Pharmaceutical Science, 1(8), 131-136. 22313354 http://hdl.handle.net/10361/7113 en © 2011 Journal of Applied Pharmaceutical Science |
institution |
Brac University |
collection |
Institutional Repository |
language |
English |
topic |
Kinetic approach Methocel K4M CR Ranolazine Sustained release |
spellingShingle |
Kinetic approach Methocel K4M CR Ranolazine Sustained release Asaduzzaman, Md. Rahman, Md. Rezowanur Rahman Khan, Md. Saifur Islam, S.M. Ashraful Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
description |
This article was published in the Journal of Applied Pharmaceutical Science [© 2011 Journal of Applied Pharmaceutical Science] |
author2 |
Department of Mathematics and Natural Sciences, BRAC University |
author_facet |
Department of Mathematics and Natural Sciences, BRAC University Asaduzzaman, Md. Rahman, Md. Rezowanur Rahman Khan, Md. Saifur Islam, S.M. Ashraful |
format |
Article |
author |
Asaduzzaman, Md. Rahman, Md. Rezowanur Rahman Khan, Md. Saifur Islam, S.M. Ashraful |
author_sort |
Asaduzzaman, Md. |
title |
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
title_short |
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
title_full |
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
title_fullStr |
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
title_full_unstemmed |
Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: In vitro drug release and kinetic approach |
title_sort |
development of sustain release matrix tablet of ranolazine based on methocel k4m cr: in vitro drug release and kinetic approach |
publisher |
© 2011 Journal of Applied Pharmaceutical Science |
publishDate |
2016 |
url |
http://hdl.handle.net/10361/7113 |
work_keys_str_mv |
AT asaduzzamanmd developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach AT rahmanmdrezowanur developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach AT rahmankhanmdsaifur developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach AT islamsmashraful developmentofsustainreleasematrixtabletofranolazinebasedonmethocelk4mcrinvitrodrugreleaseandkineticapproach |
_version_ |
1814307530555260928 |